DK1032429T3 - Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur - Google Patents
Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparaturInfo
- Publication number
- DK1032429T3 DK1032429T3 DK98962403T DK98962403T DK1032429T3 DK 1032429 T3 DK1032429 T3 DK 1032429T3 DK 98962403 T DK98962403 T DK 98962403T DK 98962403 T DK98962403 T DK 98962403T DK 1032429 T3 DK1032429 T3 DK 1032429T3
- Authority
- DK
- Denmark
- Prior art keywords
- needle
- protein
- free apparatus
- vivo
- mammal
- Prior art date
Links
- 238000001727 in vivo Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- 108010076282 Factor IX Proteins 0.000 abstract 1
- 108010071289 Factor XIII Proteins 0.000 abstract 1
- 101001059240 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Site-specific recombinase Flp Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960004222 factor ix Drugs 0.000 abstract 1
- 229940012444 factor xiii Drugs 0.000 abstract 1
- 230000009395 genetic defect Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97120384 | 1997-11-20 | ||
| PCT/EP1998/007812 WO1999026662A1 (en) | 1997-11-20 | 1998-11-20 | A method for in vivo dna delivery using a needle free apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1032429T3 true DK1032429T3 (da) | 2003-09-22 |
Family
ID=8227650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98962403T DK1032429T3 (da) | 1997-11-20 | 1998-11-20 | Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1032429B1 (es) |
| AT (1) | ATE241387T1 (es) |
| AU (1) | AU753976B2 (es) |
| CA (1) | CA2310029A1 (es) |
| DE (1) | DE69815144T2 (es) |
| DK (1) | DK1032429T3 (es) |
| ES (1) | ES2198780T3 (es) |
| PT (1) | PT1032429E (es) |
| WO (1) | WO1999026662A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| CA2367692A1 (en) * | 1999-03-15 | 2000-09-21 | Introgen Therapeutics, Inc. | Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses |
| DK1372708T3 (da) | 2001-02-13 | 2008-10-20 | Us Gov Sec Army | Vaccine til transkutan immunisering mod rejsediarre |
| EP1888105A2 (en) | 2005-05-12 | 2008-02-20 | Introgen Therapeutics, Inc. | P53 vaccines for the treatment of cancers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2641190B3 (fr) * | 1989-01-05 | 1991-09-20 | Akra | Injecteur sans aiguille |
| TW360548B (en) * | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
-
1998
- 1998-11-20 DK DK98962403T patent/DK1032429T3/da active
- 1998-11-20 AU AU17579/99A patent/AU753976B2/en not_active Ceased
- 1998-11-20 WO PCT/EP1998/007812 patent/WO1999026662A1/en not_active Ceased
- 1998-11-20 AT AT98962403T patent/ATE241387T1/de not_active IP Right Cessation
- 1998-11-20 PT PT98962403T patent/PT1032429E/pt unknown
- 1998-11-20 ES ES98962403T patent/ES2198780T3/es not_active Expired - Lifetime
- 1998-11-20 DE DE69815144T patent/DE69815144T2/de not_active Expired - Fee Related
- 1998-11-20 EP EP98962403A patent/EP1032429B1/en not_active Expired - Lifetime
- 1998-11-20 CA CA002310029A patent/CA2310029A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2198780T3 (es) | 2004-02-01 |
| EP1032429B1 (en) | 2003-05-28 |
| CA2310029A1 (en) | 1999-06-03 |
| PT1032429E (pt) | 2003-10-31 |
| AU753976B2 (en) | 2002-10-31 |
| EP1032429A1 (en) | 2000-09-06 |
| AU1757999A (en) | 1999-06-15 |
| ATE241387T1 (de) | 2003-06-15 |
| DE69815144T2 (de) | 2004-04-01 |
| WO1999026662A1 (en) | 1999-06-03 |
| DE69815144D1 (de) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835085D1 (de) | Regulation der transcription in säugetierzellen und viraler replikation durch eine tetracyclinrepressor | |
| DE69630890D1 (de) | Peptid-immitierende substanzen in der krebstherapie | |
| DE69731611D1 (de) | Eine Zusammensetzung enthaltend eine Detergenz und einen ein Tumorsuppressorgen kodierenden, adenoviralen Vektor | |
| DK85786D0 (da) | Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf | |
| DE69028694D1 (de) | Verfahren und zubereitungen zur krebsbehandlung mit oligonukleotiden | |
| EP1927660A3 (en) | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions | |
| FI955552A0 (fi) | Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa | |
| PT1062321E (pt) | Utilizacoes para celulas estaminais mesenquimais humanas nao autologas | |
| RU2007142645A (ru) | Способ лечения или профилактики рака посредством использования композиций, содержащих альфа-2-макроглобулин | |
| DE69703689D1 (de) | Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia | |
| NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
| ATE461707T1 (de) | Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug | |
| DK1032429T3 (da) | Fremgangsmåde til DNA-afgivelse in vivo ved anvendelse af et nålefrit apparatur | |
| ATE226094T1 (de) | Verfahren zur arzneistoffabgabe mittels gentherapie | |
| BR9707994A (pt) | Adenovírus recombinantes defectivo composição farmacêutica utilização do adenovirus composição e processo de preparação de células t citotóxicas especificas de um antigene tumoral | |
| Hasegawa et al. | Single‐cell transcriptome analysis of fractional CO2 laser efficiency in treating a mouse model of alopecia | |
| DE60036105D1 (de) | Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs | |
| ATE287722T1 (de) | Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1 | |
| ES2114615T3 (es) | Nueva sonda para el diagnostico de tumores o la terapia de tumores. | |
| DE60133104D1 (de) | Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren | |
| HUP0002913A2 (hu) | Eljárások és készítmények szekretált fehérjéket, például béta-interferont kódoló géneket alkalmazó terápiára | |
| Hu et al. | Enhanced skin wound healing through chemically modified messenger RNA encoding epidermal growth factor (EGF) | |
| Hu et al. | A transient photoactivation of epidermal stem cells by femtosecond laser promotes skin wound healing | |
| ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
| DE59510829D1 (de) | Gentherapeutisches verfahren unter verwendung von dna-vektoren ohne selektionsmarker-gen |